Clinical Trial Update: Supplementation of Polyunsaturated Fatty Acids in Children With Attention Deficit/Hyperactivity Disorder (ADHD) [Phase 1, Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 1/Phase 2 trial investigating supplementation with polyunsaturated fatty acids in children with ADHD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Polyunsaturated fatty acids supplementation (polyunsaturated fatty acids)

Snippet

Sponsor: Medical University of Warsaw | Conditions: ADHD | Phase 1, Phase 2 | Status: COMPLETED